Lineage Cell Therapeutics Inc (A:LCTX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for LCTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 22nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Kingsley Alfred D Indirect Ownership Common Shares, no par value Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 14/20 Kingsley Alfred D Indirect Ownership Common Shares, no par value Form 5 : Annual Statement of Beneficial Ownership of Securities    
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -15,450  
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Common Shares, no par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,343 $0.890
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Common Shares, no par value M - Exercise or conversion exempt under rule 16b-3 15,450  
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -15,450  
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Common Shares, no par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,343 $0.980
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Common Shares, no par value M - Exercise or conversion exempt under rule 16b-3 15,450  
Sep 19/19 Sep 17/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -61,800  
Sep 19/19 Sep 17/19 Culley Brian M Direct Ownership Common Shares, no par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -21,371 $1.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LCTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 22nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Kingsley Alfred D Indirect Ownership Common Shares, no par value Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 14/20 Kingsley Alfred D Indirect Ownership Common Shares, no par value Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Sep 1/19 Kingsley Alfred D Direct Ownership Common Shares, no par value Form 5 : Annual Statement of Beneficial Ownership of Securities -32,000  
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -15,450  
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Common Shares, no par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,343 $0.890
Dec 31/19 Dec 31/19 Culley Brian M Direct Ownership Common Shares, no par value M - Exercise or conversion exempt under rule 16b-3 15,450  
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -15,450  
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Common Shares, no par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,343 $0.980
Oct 1/19 Sep 30/19 Culley Brian M Direct Ownership Common Shares, no par value M - Exercise or conversion exempt under rule 16b-3 15,450  
Sep 19/19 Sep 17/19 Culley Brian M Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -61,800  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LCTX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)